Clinical observation of alprostadil alfadex on patients with vertebrobasilar insufficiency

俞海泓,张霞萍,丁萍,魏文石
DOI: https://doi.org/10.3969/j.issn.1000-8535.2007.02.012
2007-01-01
Abstract:Objective To observe the efficacy of alprostadil alfadex injection on patients with vertebrobasilar insufficiency. Methods 62 cases of vertebrobasilar insufficiency were divided into treatment group(alprostadil alfadex 30 cases)and a control group(Salvia miltiorrhiza 32 cases). Patients in the treatment group received alprostadil alfadex(alprostadil alfadex 40 μg in 100 ml saline, iv, gtt)daily for 14 day, while those in the control group were daily treated with salvia miltionrrhiza(salvia miltiorrhiza 20 ml diluted in 250 ml saline, iv, gtt)for 14 days. In addition, both group received conventional treatment with aspirin, betahistine and nimodipime. Results The overall efficacy of the treatment group(90%)is much higher than that of the control group(71.9%)(P<0.05). Conclusion Alprostadil alfadex is effective in the treatment of vertebrobasilar insufficiency.
What problem does this paper attempt to address?